Erectile Dysfunction May Improve by Blood Pressure Control in Patients with High-Risk Hypertension

References

• . NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA. 1993;270(1):83–90
   PubMed Web of Science ®Google Scholar
• . Lue TF. Erectile dysfunction. N Engl J Med. 2000;342(24):1802–1813
   PubMed Web of Science ®Google Scholar
• . Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120(2):151–157
   PubMed Web of Science ®Google Scholar
• . Chew KK, Earle CM, Stuckey BG, Jamrozik K, Keogh EJ. Erectile dysfunction in general medicine practice: prevalence and clinical correlates. Int J Impot Res. 2000;12(1):41–45
   PubMed Web of Science ®Google Scholar
• . Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54–61
   PubMed Web of Science ®Google Scholar
• . Maroto-Montero JM, Portuondo-Maseda MT, Lozano-Suárez M, . Erectile dysfunction in patients in a cardiac rehabilitation program. Rev Esp Cardiol. 2008;61(9):917–922
   PubMed Web of Science ®Google Scholar
• . Inman BA, Sauver JL, Jacobson DJ, . A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc. 2009;84(2):108–113
   PubMed Web of Science ®Google Scholar
• . Nehra A. Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions. Mayo Clin Proc. 2009;84(2):139–148
   PubMed Web of Science ®Google Scholar
• . Kushiro T, Takahashi A, Saito F, . Erectile dysfunction and its influence on quality of life in patients with essential hypertension. Am J Hypertens. 2005;18(3):427–430
   PubMed Web of Science ®Google Scholar
• . Miner MM. Erectile dysfunction and the “window of curability”: a harbinger of cardiovascular events. Mayo Clin Proc. 2009;84(2):102–104
   PubMed Web of Science ®Google Scholar
• . Cordero A, Bertomeu-Martínez V, Mazon P, . Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents. Cardiovasc Ther. 2010;28(1):15–22
   PubMed Web of Science ®Google Scholar
• . Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010;303(20):2043–2050
   PubMed Web of Science ®Google Scholar
• . O'Donnell MJ, Xavier D, Liu L, . Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTER-STROKE study): a case-control study. Lancet. 2010;376(9735):112–123
   PubMed Web of Science ®Google Scholar
• . Chamnan P, Simmons RK, Khaw KT, Wareham NJ, Griffin SJ. Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study. BMJ. 2010;340:c1693
   Google Scholar
• . Wijeysundera HC, Machado M, Farahati F, . Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994–2005. JAMA. 2010;303(18):1841–1847
   PubMed Web of Science ®Google Scholar
• . Mancia G, De Backer G, Dominiczak A, ; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25(6):1105–1187
   PubMed Web of Science ®Google Scholar
• . Chobanian AV, Bakris GL, Black HR, ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560–2572
   PubMed Web of Science ®Google Scholar
• . Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–2497
   PubMed Web of Science ®Google Scholar
• . K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 suppl 1):1–266
   PubMed Web of Science ®Google Scholar
• . Parazzini F, Menchini FF, Bortolotti A, . Frequency and determinants of erectile dysfunction in Italy. Eur Urol. 2000;37(1):43–49
   PubMed Web of Science ®Google Scholar
• . Aranda P, Ruilope LM, Calvo C, Luque M, Coca A, Gil de MA. Erectile dysfunction in essential arterial hypertension and effects of sildenafil: results of a Spanish national study. Am J Hypertens. 2004;17(2):139–145
   PubMed Web of Science ®Google Scholar
• . Lemogne C, Ledru F, Bonierbale M, Consoli SM. Erectile dysfunction and depressive mood in men with coronary heart disease [published online ahead of print September 11, 2008]. Int J Cardiol.
   Google Scholar
• . Hodges LD, Kirby M, Solanki J, O'Donnell J, Brodie DA. The temporal relationship between erectile dysfunction and cardiovascular disease. Int J Clin Pract. 2007;61(12):2019–2025
   PubMed Web of Science ®Google Scholar
• . Vlachopoulos C, Aznaouridis K, Ioakeimidis N, . Arterial function and intima-media thickness in hypertensive patients with erectile dysfunction. J Hypertens. 2008;26(9):1829–1836
   PubMed Web of Science ®Google Scholar
• . Uslu N, Gorgulu S, Alper AT, . Erectile dysfunction as a generalized vascular dysfunction. J Am Soc Echocardiogr. 2006;19(3):341–346
   PubMed Web of Science ®Google Scholar
• . Lavie CJ, Messerli FH, Milani RV. Beta-blockers as first-line anti-hypertensive therapy the crumbling continues. J Am Coll Cardiol. 2009;54(13):1162–1164
   PubMed Web of Science ®Google Scholar
• . Bangalore S, Sawhney S, Messerli FH. Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension. J Am Coll Cardiol. 2008;52(18):1482–1489
   PubMed Web of Science ®Google Scholar
• . Lindholm LH, Carlberg B, Samuelsson O. Should beta-blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet. 2005;366(9496):1545–1553
   PubMed Web of Science ®Google Scholar
• . Bakris GL, Fonseca V, Katholi RE, ; GEMINI Investigators. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA. 2004;292(18):2227–2236
   PubMed Web of Science ®Google Scholar
• . Kindermann M, Maack C, Schaller S, . Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo. Circulation. 2004;109(25):3182–3190
   PubMed Web of Science ®Google Scholar
• . Gabriel R, Alonso M, Segura A, ; ERICE Cooperative Group. Prevalence, geographic distribution and geographic variability of major cardiovascular risk factors in Spain. Pooled analysis of data from population-based epidemiological studies: the ERICE Study. Rev Esp Cardiol. 2008;61(10):1030–1040
   PubMed Web of Science ®Google Scholar
• . Lloyd-Jones D, Adams RJ, Brown TM, ; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2010 update: a report from the American Heart Association. Circulation. 2010;121(7):e46–e215
   PubMed Web of Science ®Google Scholar
• . Friedman O, McAlister FA, Yun L, Campbell NR, Tu K. Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in Ontario. Am J Med. 2010;123(2):173–181
   PubMed Web of Science ®Google Scholar
• . Broeders MA, Doevendans PA, Bekkers BC, . Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production. Circulation. 2000;102(6):677–684
   PubMed Web of Science ®Google Scholar
• . Dessy C, Saliez J, Ghisdal P, . Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol. Circulation. 2005;112(8):1198–1205
   PubMed Web of Science ®Google Scholar
• . Cocco G. Erectile dysfunction after therapy with metoprolol: the Hawthorne effect. Cardiology. 2009;112(3):174–177
   PubMed Web of Science ®Google Scholar
• . Silvestri A, Galetta P, Cerquetani E, . Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo. Eur Heart J. 2003;24(21):1928–1932
   PubMed Web of Science ®Google Scholar